phytosterols and Parkinson-Disease

phytosterols has been researched along with Parkinson-Disease* in 2 studies

Reviews

1 review(s) available for phytosterols and Parkinson-Disease

ArticleYear
A novel function for glucocerebrosidase as a regulator of sterylglucoside metabolism.
    Biochimica et biophysica acta. General subjects, 2017, Volume: 1861, Issue:10

    Sterols are major cell membrane lipids, and in many organisms they are modified with glucose to generate sterylglucosides. Glucosylation dramatically changes the functional properties of sterols. The formation of sterylglucosides from sterols in plants, fungi, and bacteria uses UDP-glucose as a glucose donor. By contrast, sterylglucoside biosynthesis in mammals is catalyzed by the transglucosylation activity of glucocerebrosidases, with glucosylceramide acting as the glucose donor. Recent success in isolation and structural determination of sterylglucosides in the vertebrate central nervous system shows that transglucosylation also occurs in vivo. These analyses also revealed that sterylglucoside aglycons are composed of several cholesterol-related metabolites, including a plant-type sitosteryl.. In this review, we discuss the biological functions and metabolism of sterylglucosides. We also summarize new findings from studies on the metabolism of vertebrate sterylglucosides and review the circumstances underlying the recent discovery of sterylglucosides in vertebrate brain. Finally, we discuss the role of sterylglucosides in a variety of neurodegenerative disorders such as Gaucher disease and Parkinson's disease.. The biological significance of UDP-glucose-independent sterol glucosylation is still unknown, but it is plausible that glucosylation may provide sterols with novel biological functions. Even though sterol glucosylation is a simple reaction, it can dramatically change the physical properties of sterols.. Sterylglucosides may play roles in various physiological processes and in the pathogenesis of different diseases. Arriving at a better understanding of them at the organ and cellular level may open up new approaches to developing therapeutics for a variety of diseases. This article is part of a Special Issue entitled Neuro-glycoscience, edited by Kenji Kadomatsu and Hiroshi Kitagawa.

    Topics: Animals; Bacteria; Cholestenes; Cholesterol; Fungi; Gaucher Disease; Gene Expression; Glucosylceramidase; Glucosylceramides; Humans; Parkinson Disease; Phytosterols; Plants; Uridine Diphosphate Glucose

2017

Other Studies

1 other study(ies) available for phytosterols and Parkinson-Disease

ArticleYear
    Journal of biomolecular structure & dynamics, 2022, Volume: 40, Issue:20

    Our previous anti-Alzheimer's studies on crude extracts, essential oils and isolated compounds including β-sitostrol from

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Ligands; Molecular Docking Simulation; Monoamine Oxidase; Parkinson Disease; Phytosterols; Polygonum; Stigmasterol

2022